Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Comparison of the Incidence of Dyskinesia in Parkinson's Disease Who Were Treated With Amantadine or Dopamine Agonist

Trial N/A Unknown May 2, 2017

Swallowing and Breathing Exercises for Dysphagia in Parkinson Disease

Trial N/A Completed April 26, 2017

Hub and Spoke, Comparative Outcomes for Parkinson's Disease Treated With Deep Brain Stimulation

Trial N/A Withdrawn April 26, 2017

Investigating Therapies for Freezing of Gait

Trial N/A Unknown April 24, 2017

Implantable Systems Performance Registry

Trial N/A Completed April 20, 2017

Expanded Access of Pimavanserin for Patients With PD Psychosis

Trial N/A Approved for marketing April 17, 2017

Safety and Efficacy Study of Human ESC-derived Neural Precursor Cells in the Treatment of Parkinson's Disease

Trial Phase 1 Unknown April 17, 2017

Cholinergic Nicotinic Receptors and Cognition in PD

Trial N/A Completed April 16, 2017

Effect of Food on Opicapone

Trial Phase 1 Completed April 16, 2017

rTMS for Motor and Mood Symptoms of Parkinson's Disease

Trial N/A Completed April 12, 2017

Risk Factors for Progressive Supranuclear Palsy (PSP)

Trial N/A Completed April 9, 2017

Mild Cognitive Impairment in Parkinson's Disease

Trial Phase 4 Completed April 6, 2017

Efficacy and Tolerability of Nebicapone in Parkinson's Disease Patients With "Wearingoff" Phenomenon

Trial Phase 2 Completed April 5, 2017

The Effects of Treadmill Training With Visual and Auditory Cues on Gait Parameters in Parkinsonian Patients in Advanced Stages of Disease.

Trial N/A Unknown April 4, 2017

Impact of Rehabilitation in Quality of Life in PD

Trial N/A Completed April 4, 2017

Effectiveness of Intensive Rehabilitation in Advanced Stages of Parkinson's Disease.

Trial N/A Unknown April 3, 2017

Handwriting Rehabilitation in Parkinson Disease

Trial N/A Unknown April 3, 2017

Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Syndromes

Trial N/A Terminated March 30, 2017

Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg

Trial Phase 1 Completed March 30, 2017

Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease

Trial Phase 4 Completed March 29, 2017